Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial

INTRODUCTION: Patients with slowly progressive autosomal dominant polycystic kidney disease (ADPKD) are unlikely to experience outcomes during randomized controlled trials (RCTs). An image classification of ADPKD into typical (diffuse cyst distribution) class 1A to E (by age- and height-adjusted tot...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Kidney Int Rep
Autores principales: Irazabal, Maria V., Blais, Jaime D., Perrone, Ronald D., Gansevoort, Ron T., Chapman, Arlene B., Devuyst, Olivier, Higashihara, Eiji, Harris, Peter C., Zhou, Wen, Ouyang, John, Czerwiec, Frank S., Torres, Vicente E.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2016
Materias:
Clinical Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5678619/
https://ncbi.nlm.nih.gov/pubmed/29142926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2016.08.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares